Lanean...
Neutralizing Antibody Responses in COVID-19 Convalescent Sera
Passive transfer of antibodies from COVID-19 convalescent patients is being used as an experimental treatment for eligible patients with SARS-CoV-2 infections. The United States Food and Drug Administration’s (FDA) guidelines for convalescent plasma initially recommended target antibody titers of 16...
Gorde:
| Argitaratua izan da: | J Infect Dis |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665673/ https://ncbi.nlm.nih.gov/pubmed/33104179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa673 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|